xMAP® Menu
Search for analytes, kits, or services; filter results and create reports.
Downloads
Corporate Fact Sheet
xMAP Technology Analyte Menu
xMAP Technical Sheet
Related Products
Instruments
Clinical Diagnostics Assays
Assay Development Tools
xPONENT® Software Solutions
Alzheimer's Disease
Description
Alzheimer’s disease is the most common age-related neurodegenerative disease, affecting as many as 5 million Americans and 24 million people world wide. It is a progressive and invariably fatal disorder, progressing from relatively insignificant loss of memory (termed Mild Cognitive Impairment) to dementia, in which affected individuals suffer profound loss of memory along with severely disrupted reasoning. It is the seventh-leading cause of death in the United States. The Luminex xMAP® Technology platform provides versatility and flexibility for construction of multiplex panels to meet the needs of both clinicians and life science researchers.
Tests available from:
